Cocaine addiction, craving, relapse: Paradigm shift in treatment holds promise, thanks to epigenetics
News May 27, 2015
One of the major challenges of cocaine addiction is the high rate of relapse after periods of withdrawal and abstinence. But new research reveals that changes in our DNA during drug withdrawal may offer promising ways of developing more effective treatments for addiction.
Withdrawal from drug use results in reprogramming of the genes in the brain that lead to addictive personality, say researchers from McGill University and Bar Ilan University in a new study published in the Journal of Neuroscience.
"We inherit our genes from our parents and these genes remain fixed throughout our life and are passed on to our children; we can do very little to change adverse genetics changes that we inherit," says Moshe Szyf, a professor in the Faculty of Medicine at McGill, "In contrast, epigenetic marks such as DNA methylation act as switches and dimmers of genes- they can be switched on, off, or dimmed -- by epigenetic drugs inhibiting DNA methylation and removing methyl marks from these genes."
The researchers wanted to see if they could stop addictive behavior by influencing the epigenetic markers that were triggered by withdrawal using epigenetic drugs such as the DNA methylation inhibitor, RG108.
Rat model of addiction
The team used a rat model of incubation of cocaine craving, in which rats were trained to self-administer cocaine which was cued by a specific light or sound. This drug craving or "addictive" behavior was tested after either 1 day or 30 days of withdrawal from cocaine. Following the long withdrawal, the rats developed an intense drug seeking behavior when exposed to the cue. It was after a lengthy period without the drugs that the epigenetic changes were most evident.
Revolutionary approach to treating drug addiction
"We discovered that injecting the drug RG108 just before the animals were exposed to the light cue after the long withdrawal not only stopped the addictive behavior of the animals, it also lasted for a longer period. This suggests that a single treatment with RG108 could reverse or perhaps cure drug addiction." adds Szyf.
Period of withdrawal is key
"Surprisingly, we discovered that the biggest changes in DNA methylation occurred not during the exposure to the drug but during withdrawal," says co-author Gal Yadid, of Bar Ilan University, "During this period of withdrawal, hundreds of genes changed their state of DNA methylation including genes that were known before to be involved in addiction."
This research may point to new avenues for treatment of addiction in humans.
Current treatments might aggravate rather than inhibit addiction
"The mainstay of current approaches to treating addiction might actually aggravate it," says Yadid. "Our research suggests that because the changes in addiction involve numerous genes, our current approaches will continue to fail if we target one or few targets in the brain, but more research is needed to confirm if these new avenues hold promise."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Yadid G et al. Role of DNA Methylation in the Nucleus Accumbens in Incubation of Cocaine Craving. Journal of Neuroscience, Published May 27 2015. doi: 10.1523/JNEUROSCI.3053-14.2015
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Biological Mechanism of a Leading Cause of Childhood Blindness RevealedNews
Scientists have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.READ MORE
Machine Learning: Helping Determine How a Drug Affects the BrainNews
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.READ MORE